@article{53f38e8748184f14aa461687fb5b1ab4,
title = "'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response",
keywords = "Antipsychotic Agents, Glucagon-Like Peptide-1 Receptor, Humans, Obesity, Schizophrenia, Letter, Research Support, Non-U.S. Gov't",
author = "Ebdrup, \{B H\} and Ish{\o}y, \{P L\} and B Fagerlund and Broberg, \{B V\} and N Bak and Knop, \{F K\} and Glenth{\o}j, \{B Y\}",
year = "2017",
month = nov,
doi = "10.1111/acps.12795",
language = "English",
volume = "136",
pages = "526--527",
journal = "Acta Psychiatrica Scandinavica",
issn = "0001-690X",
publisher = "John Wiley and Sons Inc.",
number = "5",
}